EcoR1 Capital’s Eikon Therapeutics EIKN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$6.88M Buy
855,634
+123,028
+17% +$1.24M 0.31% 28
2026
Q2
$9.6M Hold
732,606
– – 0.46% 22
2026
Q1
$7.75M Buy
+732,606
New +$9.8M 0.33% 20

Other funds holding EIKN

EcoR1 Capital's EIKN Position: Q3 2026 in Review

EcoR1 Capital increased its Eikon Therapeutics (EIKN) stake by 17% in Q3 2026, buying an estimated $1.24M and bringing the position to 855,634 shares worth $6.88M. The position accounts for 0.31% of the portfolio, ranked #28.

EcoR1 Capital first reported a position in EIKN in Q1 2026 and has held it in 3 quarters since. The position peaked at $9.6M in Q2 2026. 98 funds tracked by Wall St. Rank hold EIKN as of Q3 2026.

  • EcoR1 Capital held 855,634 shares of Eikon Therapeutics worth $6.88M as of Q3 2026.
  • EcoR1 Capital bought 123,028 Eikon Therapeutics shares in Q3 2026, an estimated $1.24M.
  • Eikon Therapeutics made up 0.31% of EcoR1 Capital's portfolio in Q3 2026, its #28 holding.
  • EcoR1 Capital first reported a position in Eikon Therapeutics in Q1 2026 and has held it in 3 quarters since.
  • EcoR1 Capital's Eikon Therapeutics position peaked at $9.6M in Q2 2026.
  • 98 funds tracked by Wall St. Rank held Eikon Therapeutics as of Q3 2026.

Based on EcoR1 Capital's 13F filing for Q3 2026, filed 16 Nov 2026.